On the positive side, good progress has been made on gender equality and fewer people are dying of unnatural causes.
Academic rigour, journalistic flair
Articles on Antiretroviral drugs
Displaying 1 - 20 of 72 articles
The US PEPFAR initiative has brought HIV medication to millions of people globally. Behind this progress are the activists that pressured politicians and companies to put patients over patents.
Dec. 1 marks World AIDS Day. Canada has the tools and means to end the epidemic. The question remains, are we up to the task?
When antiretroviral therapy is working effectively, HIV cannot be transmitted. This allows people with HIV to live fuller lives without the fear of infecting others.
People with HIV need to take daily medication to keep the virus at bay. A study has found that a new treatment combination could boost immunity and control virus levels even after stopping medication.
Much remains to be resolved before the waiver is translated into increased vaccine supply.
The giant leap in the number of people accessing HIV treatment would not have been possible without task shifting from medical doctors to less-specialised cadres such as nurses and midwives.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
Our findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.
Providing antiretroviral therapy without incorporating quality diets may not help to reduce illness and death related to HIV.
The discovery of a new strain of HIV gives scientists a better understanding of the virus.
HIV is a condition that must be managed, not just medically, but also socially, tackling stigma, social anxieties and the risks of disclosure.
The study confirms that dolutegravir is an effective and well-tolerated ARV.
Most of the reasons people don’t take their medication aren’t related to the antiretrovirals themselves, but rather social and systemic issues.
The global cancer burden especially in developing countries is exacerbated by the high cost of treatment.
World AIDS Day is Dec. 1. With many advances in preventing and treating the disease, the disease has fallen from top of mind for many. An epidemiologist explains why that could be dangerous.
HIV negative children born to women with HIV have a greater risk of dying before their first birthday.
Introducing viral load testing at health facilities can help South Africa reach the United Nations target to end AIDS.
In Uganda stand-alone clinics for HIV treatment persist because of stigma and overcrowding.
Women and children remain the focus of HIV while men are disadvantaged in accessing testing and treatment in Africa.
Job Board
-
Professor - Criminology
-
Research Assistant - Dewson Lab
-
Director, Business Development, AICF
-
Research Fellow in Human-Computer Interaction
-
Commissioning Editor, Health
Top contributors
-
Senior Research Fellow, Kirby Institute, UNSW Sydney
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
-
Health Systems Researcher, Makerere University
-
University of the Witwatersrand
-
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
-
Professor of Global Health and Director, O'Neill Institute, Georgetown University
-
Public Health Medicine Specialist, University of the Witwatersrand
-
Associate Professor, Computing & Information Systems; Director, Melbourne Data Analytics Platform, The University of Melbourne
-
Honorary Professor, University of Cape Town
-
University Research Lecturer and Honorary Consultant Physician, University of Oxford
-
Associate Professor and Principal Research Fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University
